Please login to read the full article.
Scrip Regulatory Affairs
The obligation to conduct paediatric studies for drugs in the EU: will Nycomed Danmark provide clarification?
17 October 2011
Manuel Campolini
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Top European court confirms validity of negative term SPCs ? welcome news for pharma industry
- European court decisions on SPCs gives drug combinations more protection
- EMA Q&As elaborate on paediatric use marketing authorisations and PIPs
- EU industry cautious about proposed penalties under pharmacovigilance and paediatric frameworks
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
